Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.

Almudena Aguilera-Saborido, Jorge Gorrin Ramos, María Eugenia Torregrosa Quesada, Enrique Mercader Cidoncha, María Rosa Bella-Cueto, Isabel Gómez Muriel, José Vicente Méndez Monter, Nieves López Lazareno, Jorge Francisco Gómez Cerezo, Paola Parra Ramírez, Jorge Gabriel Ruiz-Sánchez, Marta Araujo-Castro, Esteban Poch, Felicia A Hanzu, Isabelle Runkle, Anna Oliveras, Josep Oriola, Patricia Martín Rojas-Marcos

Journal: Endocrine 2024;85(1):99-121

PMID: 38448679

Full Text on Springer View on PubMed

Abstract

Primary aldosteronism (PA) is the most frequent cause of secondary hypertension (HT), and is associated with a higher cardiometabolic risk than essential HT. However, PA remains underdiagnosed, probably due to several difficulties clinicians usually find in performing its diagnosis and subtype classification. The aim of this consensus is to provide practical recommendations focused on the prevalence and the diagnosis of PA and the clinical implications of aldosterone excess, from a multidisciplinary perspective, in a nominal group consensus approach by experts from the Spanish Society of Endocrinology and Nutrition (SEEN), Spanish Society of Cardiology (SEC), Spanish Society of Nephrology (SEN), Spanish Society of Internal Medicine (SEMI), Spanish Radiology Society (SERAM), Spanish Society of Vascular and Interventional Radiology (SERVEI), Spanish Society of Laboratory Medicine (SEQC(ML)), Spanish Society of Anatomic-Pathology, Spanish Association of Surgeons (AEC).

Address: Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS)., Madrid, Spain. [email protected].; Endocrinology & Nutrition Department. Hospital Universitario Fundación Jiménez Díaz, Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.; Endocrinology & Nutrition Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Cardiology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Internal Medicine, Hospital Universitario Infanta Sofía. Universidad Europea de Madrid, Madrid, Spain.; Biochemical Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Biochemical Department, Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain.; Biochemical department, Laboratori de Referència de Catalunya, Barcelona, Spain.; Biochemistry and Molecular Genetics Department, CDB. Hospital Clínic. University of Barcelona, Barcelona, Spain.; Nephrology Department. Hospital Clinic, IDIBAPS. University of Barcelona, Barcelona, Spain.; Nephrology Department. Hospital del Mar, Universitat Pompeu Fabra, Barcelona, ES, Spain.; Vascular and Interventional Radiology Department, Hospital Clínico San Carlos, Madrid, Spain.; Radiology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Pathology Department, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA). Universitat Autònoma de Barcelona. Sabadell, Barcelona, Spain.; General Surgery, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Fellow European Board of Surgery -Endocrine Surgery, Madrid, Spain.; Endocrinology and Nutrition Department, Hospital Clínico San Carlos, Madrid, Spain.; Endocrinology & Nutrition Department, Hospital Clinic. IDIBAPS. University of Barcelona, Barcelona, Spain. [email protected].

DOI: 10.1007/s12020-024-03751-1

Link outs

Subscription / membership required

Full Text Sources:

https://dx.doi.org/10.1007/s12020-024-03751-1

MeSH Terms: Humans, Consensus, Hyperaldosteronism, Hypertension, Mass Screening, Societies, Medical, Spain